The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

Investment Ideas Served Daily By People You Trust
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

1 point   posted on 07/30/09
Arrow_up
Arrow_down
N/A
+0.00%

A FREE report on the approval of a new Gout Drug


An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to treat. To read about whether this small cap company has chances to get their drug approved, get a FREE report at: http://www.newbiomedicine.com

  Related to:  
AFFY Affymax Inc.


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment




 
Affymax Inc. (AFFY)
   SocialPicks Sentiment:    N/A

   This Quarter's Sentiment:
All:
100.0%
Top:
0.0%




TODAY'S HEADLINES





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch